Universe Pharmaceuticals (UPC) has released an update.
Universe Pharmaceuticals has confirmed its agreement with the contents of Form 6-K filed on October 10, 2024, as it relates to their firm, according to their CPA firm YCM CPA Inc. The statement reflects the company’s current financial positioning and operational results, which could be of interest to investors tracking pharmaceutical stocks.
For further insights into UPC stock, check out TipRanks’ Stock Analysis page.
